In the newly developed vimentin-immunized SSc model, the levels of pro-inflammatory cytokines, autoantibodies, and activated immune cells in the analyzed tissues were significantly elevated compared to controls, demonstrating successful induction of both autoimmune and fibrotic pathology. Here, VIM is linked to systemic sclerosis.